Thank you for expressing interest in using the Clinical Assessment Interview for Negative Symptoms (CAINS).
The CAINS was developed by the CANSAS Collaborative Group (Collaboration to Advance Negative Symptom Assessment in Schizophrenia Research): Jack J. Blanchard, Raquel E. Gur, William P. Horan, and Ann M. Kring.
Before providing access to the training materials, we ask that you provide assurance that:
- You are a qualified investigator, or working with a qualified investigator, or a clinician;
- Your studies will be conducted with approval of an Institutional Review Board, or similar regulatory body, and with oversight for protection of human participants.
- CAINS is copyrighted and is for research and clinical purposes in academic, industrial and clinical settings; You or your team will not use it for commercial use.
- Any publications generated from studies using the CAINS reference their origin. Specific citation information is provided below and should be consulted as you prepare your manuscript or presentation. Once published, we would appreciate receiving reprints of any publications using the CAINS.
- Citations for Publications
- Forbes, C., Blanchard J.J., Bennett, M., Horan, W.P., Kring, A.M., Gur, R.E. (2010). Initial Development and Preliminary Validation of a New Negative Symptom Measure: The Clinical Assessment Inventory for Negative Symptoms. Schizophrenia Research, 124, 36-42.
- Blanchard, J.J., Kring, A.M., Horan, W.P., Gur, R.E. (2011). Toward the Next Generation of Negative Symptom Assessments: The Collaboration for the Advancement of Negative Symptom Assessment in Schizophrenia. Schizophrenia Bulletin, 37, 291-299.
- Horan, W.P., Kring, A.M., Gur, R.E., Reise, S.P., Blanchard, J.J. (2011). Development and Psychometric Validation of the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophrenia Research, 132, 140-145.
- Kring, A. M., Gur, R. E., Blanchard, J. J., Horan, W. P., Reise, S. P., & (2013). The Clinical Assessment Interview for Negative Symptoms (CAINS): Final development and validation. American Journal of Psychiatry, 170, 165-172.